Ubie
Ubie is a Tokyo-based health-tech company founded in 2017 that builds AI-powered symptom checking, patient intake, and triage tools used by 1,000+ medical institutions and 13 million monthly users, monetizing via B2B subscriptions, pharma advertising, and data partnerships across Japan and the US.
- Company typePrivate
- Founded2017
- HeadquartersTokyo, Japan
- Headcount251–500
- GTM typeB2B and B2C
- OfferingSoftware
What Ubie does
Ubie is a Tokyo-headquartered health-tech company founded in 2017 that builds AI-powered healthcare prediction and patient engagement tools. Its core products include an AI Symptom Checker used by over 1,000 medical institutions worldwide and millions of monthly users, an AI-driven Patient Intake Service that automates pre-consultation data collection, and a Medical Data Platform connecting patients, healthcare providers, and pharmaceutical companies in Japan and the United States. The portfolio expanded materially in 2026 to include Consult, a doctor-approved chat-based LLM trained on over 50,000 peer-reviewed publications and validated by more than 50 medical specialists, and Smart Support, an AI-powered digital front door platform co-developed with Mayo Clinic that integrates chat and voice interfaces with symptom assessment, triage, and self-scheduling. The company has also launched Ubie Self-Serve, a targeted advertising platform for pharmaceutical companies.
The underlying technology combines large language models, generative AI, and predictive analytics built on a clinically validated symptom-to-condition pipeline. Ubie reports higher triage accuracy than generic LLMs, which it cites as correctly identifying conditions in fewer than 34.5% of cases. A wholly-owned US subsidiary established in 2022 supports international expansion, with reported metrics of 13 million global monthly users as of March 2026 (2 million in the US), 25% month-over-month user growth, and an 85% increase in US organic users since 2024. Cumulative funding since 2017 exceeds $125 million across rounds led by Japanese financial institutions (Dai-ichi Life, Norinchukin Capital, MUFG, Mizuho, Sumitomo Mitsui Trust), and corporate investors including Google, NTT DOCOMO Ventures, Seven-Eleven Japan, and Japan Post Capital.
The business model combines three revenue streams: B2B subscriptions from healthcare institutions using the Symptom Checker and Patient Intake Service, advertising revenue from the Ubie Self-Serve platform (launched June 2026 with $100/day entry pricing for pharmaceutical advertisers targeting by symptom and disease prediction), and data/partnership programs connecting patients, providers, and pharmaceutical companies. The company serves 1,000+ medical institutions, millions of B2C users across Japan and the US, and counts Mayo Clinic as a flagship enterprise partner alongside major Japanese banks and corporate investors as financial backers.
Ubie firmographics
Firmographics- Name
- Ubie
- Legal name
- Ubie株式会社
- Website
- https://ubie.life
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Ubie is a Tokyo-based health-tech company founded in 2017 that builds AI-powered symptom checking, patient intake, and triage tools used by 1,000+ medical institutions and 13 million monthly users, monetizing via B2B subscriptions, pharma advertising, and data partnerships across Japan and the US.
- Ownership category
- akta.pro rank
Ubie industry classification
Industry- Product category
- Healthcare AI Platform
- NAICS
- Software Publishers (5132), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)
- akta.pro secondary industries
- Prompt Engineering, Orchestration & LLMOps Tooling (HDAAACAD), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where Ubie is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices2 records
Markets served
Ubie business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- B2B Healthcare Solutions: Provides AI-powered tools to healthcare institutions including symptom checker and patient intake services used by over 1,000 medical institutions worldwide
- Healthcare Advertising Platform: Ubie Self-Serve advertising platform enabling pharmaceutical companies to target patients based on symptoms, disease predictions, and specialty interests within AI-driven healthcare experiences
- Pharmaceutical Partnerships: Medical data platform connecting patients, medical institutions, and pharmaceutical companies to improve healthcare information sharing and operational efficiency
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Pay-as-you-go | Ubie Self-Serve advertising platform starting price |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
Ubie product offering
Product offeringCore offering
Ubie develops and operates an AI-powered healthcare prediction platform built on large language models and generative AI. Its commercial offerings include a consumer-facing AI Symptom Checker, an AI Patient Intake Service deployed at more than 1,000 medical institutions worldwide, an LLM-based patient consultation product (Consult), an enterprise digital front-door platform (Smart Support, co-developed with Mayo Clinic), and a self-serve healthcare advertising platform for pharmaceutical buyers.
Product overview
Ubie is a health technology company offering a suite of AI-powered healthcare prediction tools. The core products include the Symptom Checker and Patient Intake Service, supported by a Medical Data Platform connecting patients, medical institutions, and pharmaceutical companies. The portfolio expands into patient-facing solutions like Consult (LLM-based chatbot) and Smart Support (AI triage and scheduling platform developed with Mayo Clinic), plus Ubie Self-Serve for pharmaceutical advertising. The company serves millions of monthly users across Japan and the US.
Differentiator
Problem solved
Functional benefit
Brands
- Ubie Consult: Doctor-approved, chat-based LLM built on clinically-validated Symptom Checker to help patients decide whether to self-manage or seek medical care.
- Ubie Self-Serve
- Ubie Smart Support
- Ubie Symptom Checker
Products and services
- Ubie Symptom Checker AI-powered symptom checker that analyzes patient symptoms to predict likely conditions and recommend next steps, used by consumers and by over 1,000 medical institutions worldwide.
- Patient Intake Service AI-powered patient intake solution that automates collection of patient information, medical history, and symptom data prior to consultations, improving operational efficiency for healthcare providers.
- Medical Data Platform Platform connecting patients, medical institutions, and pharmaceutical companies to improve healthcare information sharing, medical data exchange, and operational efficiency in Japan and the US.
- Consult Doctor-approved, chat-based LLM built on Ubie's clinically-validated Symptom Checker that helps patients decide whether to self-manage or seek medical care, with content validated by over 50 medical specialists.
- Smart Support AI-powered digital front door platform co-developed with Mayo Clinic that integrates chat and voice interfaces with clinically validated symptom assessment, triage, and self-scheduling, with planned chronic disease management capabilities.
- Ubie Self-Serve Self-serve targeted healthcare advertising platform enabling pharmaceutical companies and media buyers to reach patients based on symptoms, disease predictions, and specialty interests within AI-driven healthcare experiences.
Quantifiable outcome
- 25% month-over-month growth in global monthly users to 13 million (March 2026)
- +2 more outcomes
Companies that use Ubie
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Ubie technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature6 records
Ubie partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, minor and flagship.
- AI Safety Institute (AISI)coreUbie's working leader collaborated with AISI to develop 'Guidelines for AI Safety Evaluation Perspectives in the Healthcare Sector', positioning Ubie as a leader in healthcare AI safety standards.
- EFPIA Japan (European Federation of Pharmaceutical Industries and Associations)minorOne of three major pharmaceutical industry associations confirming as sponsors of Ubie Pharma Summit 2026 conference to be held May 13-14, 2026 in Tokyo, focused on AI and information technology integration in pharmaceutical industry.
- Japan Pharmaceutical Manufacturers Association (JPMA)minorJapanese pharmaceutical industry association sponsoring Ubie Pharma Summit 2026, participating in joint panel discussion on patient-centered healthcare solutions using AI.
- PhRMA (Pharmaceutical Research and Manufacturers of America)minorUS pharmaceutical industry association confirming as sponsor of Ubie Pharma Summit 2026 and participating in joint panel discussion alongside EFPIA Japan and JPMA.
- Mayo ClinicflagshipUbie announced collaboration with Mayo Clinic to co-develop Ubie Smart Support, an AI-powered platform designed to unify fragmented digital healthcare access points into a single enterprise-grade patient experience. The platform integrates chat and voice interfaces with clinically validated symptom assessment, triage, and self-scheduling capabilities. Collaboration followed Ubie's 30-week pilot in Mayo Clinic's Platform Accelerate program.
Scale indicators9 records
Recent moves6 records
Expansion highlights7 records
Ubie competitors and assessment
Company assessmentDirect peers
- Ada Health: Direct competitor in AI-powered symptom checking and triage. Ada Health offers a consumer symptom assessment app and enterprise partnerships with health systems and insurers, mirroring Ubie's patient-facing and B2B go-to-market.
- Babylon Health: Pioneer in AI symptom triage and digital care delivery, now operating as Babylon by Evernorth. Direct comparable on AI symptom checker and triage layer integrated into health system and payer offerings.
- K Health: AI-driven primary care platform with symptom-to-condition chatbot and affiliated clinical services. Compares on AI symptom assessment combined with care navigation and telemedicine in the US.
- Mediktor: Spain-based AI symptom checker sold to health systems, insurers, and pharma. Direct competitor in white-label clinical triage AI for hospital digital front doors.
- Buoy Health: US-based AI symptom checker and care navigation tool offered to health plans and providers. Directly comparable on AI triage and digital front-door orientation.
Emerging players
- Suki AI: AI clinical documentation and ambient scribe for physicians. Adjacent competitor for the generative AI documentation feature Ubie launched in 2023, competing for the same clinical workflow budget.
- Doximity: Physician-facing digital platform with growing AI scribe tools (Doximity GPT). Adjacent competitor for clinician mind-share and digital workflow budgets.
Broad incumbents
- Microsoft Cloud for Healthcare: Microsoft's broader healthcare platform offering AI capabilities for health systems, including clinician copilots and patient engagement. Represents the strategic incumbent threat with deeper health system distribution than Ubie.
- Google Health / MedLM: Google's healthcare AI initiatives including MedLM and Fitbit health services. Notable as both a Ubie investor and potential platform competitor given Google's foundation model and cloud distribution advantages.
- WebMD: Legacy consumer health information and symptom-checker platform with massive consumer traffic. Indirect competitor for consumer symptom assessment and pharma advertising dollars.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Ubie social profiles
Digital presenceUbie financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ubie leadership team
Management profileNumber of profiles
Profiles3 records
Ubie subsidiaries and ownership
Company hierarchySubsidiaries1 record
Ubie funding detail
Funding detailFunding overview
Funding rounds13 records
Investors22 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ubie M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ubie
What does Ubie do?
Ubie develops and operates an AI-powered healthcare prediction platform built on large language models and generative AI. Its commercial offerings include a consumer-facing AI Symptom Checker, an AI Patient Intake Service deployed at more than 1,000 medical institutions worldwide, an LLM-based patient consultation product (Consult), an enterprise digital front-door platform (Smart Support, co-developed with Mayo Clinic), and a self-serve healthcare advertising platform for pharmaceutical buyers.
Is Ubie a public or private company?
Ubie is a private company. It is classified as venture growth investor backed and is currently operating.
When was Ubie founded?
Ubie was founded in 2017. It employs 251 to 500 people.
Where is Ubie based?
Ubie is headquartered in Tokyo, Japan, in the Asia region.
How does Ubie make money?
Three revenue lines are on record. B2B Healthcare Solutions are the primary driver. The others are healthcare Advertising Platform and pharmaceutical Partnerships.
Who are Ubie's main competitors?
Direct peers on record are Ada Health, Babylon Health, K Health, Mediktor and Buoy Health. Emerging players are Suki AI and Doximity. Broad incumbents are Microsoft Cloud for Healthcare, Google Health / MedLM and WebMD.
Does Ubie have an API?
No public API is recorded for Ubie.
What industry is Ubie in?
Ubie's product category is Healthcare AI Platform. Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software, with a secondary code of HDAAACAD, Prompt Engineering, Orchestration & LLMOps Tooling. Its NAICS code is 5132 and its SIC code is 7372.